CI & Patents: 15/01/2011


1) Merck, Parexel Reach Biosimilar Development Deal.

2) Sanofi-aventis Enters into Two Research & Development Collaborations with the University of California, San Francisco  “….The first  collaboration promotes innovative research in pharmacological science and in multiple therapeutic areas, such as oncology, aging, diabetes and inflammation. The second collaboration is an oncology partnership that will focus on project-based collaboration to accelerate the progression of research through the clinical proof of concept stage…”

3) Merck Patent medicine journal includes new entry (addendum C): Patent number is 221123 (exp: 15-Jul-2018); Medicine protected: Not identified (will be updated)

4) US litigations

(i) Glaxo sues over prostate-drug patents (Link): GlaxoSmithKline vs Anchen Pharmaceuticals Inc/Banner Pharmacaps (product: Dutasteride) filed at Delaware District on Jan 12, 2011 (View on RFC)

(ii) Shire Canada Inc vs Alkem Laboratories Ltd (product: Lanthanum carbonate) patents in suit: 7,465,465 & 5,968,976; filed at District of Illinois on Jan 12, 2011 View on PriorSmart.

(iii) Allergan vs Sandoz (product: Tropsium chloride) patents in suit: 7,781,448; 7,781,449; 7,759,359; 7,763,635 & 7,410,978; filed at Delaware on Jan 12, 2011 View on PriorSmart.

(iv) Aventis Pharma S.A vs Sandoz Inc (product: Docetaxel) patents in suit: 5,714,512; filed at Delaware on Jan 12, 2011 View on PriorSmart.

(v) Bayer Schering Pharma AG vs Sun Pharma (product: Drospirenone; Ethinyl Estradiol) patents in suit: RE37564; RE37838 & RE38253; filed at District of Nevada on Jan 12, 2011 View on PriorSmart

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news, Patent case. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s